Knight to Present at 2026 Healthcare Investor Conference

MONTREAL, April 15, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to present a corporate update at the 2026 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 21, 2026, at 2:00 p.m. ET at the Metro Toronto Convention Centre (North Building) in Toronto. A copy of the presentation will be available at www.knighttx.com.

On April 15, 2026, Knight Therapeutics Inc. announced that it will be presenting at the highly anticipated Bloom Burton & Co. Healthcare Investor Conference. The event is set to take place in Toronto, Canada, where various leaders in the healthcare investment community will gather to explore innovative companies and investment opportunities in the healthcare sector. Knight Therapeutics, known for its commitment to developing and commercializing pharmaceutical products, is expected to showcase its strategic growth initiatives and advancements in its pipeline.

The Bloom Burton & Co. Healthcare Investor Conference is a vital platform for companies like Knight to connect with institutional investors, analysts, and other stakeholders. This event allows companies to present their business models, financial health, and future outlooks, facilitating informed investment decisions. Knight's presence at this conference marks a significant opportunity to attract interest from potential investors as the company highlights its achievements and future direction.

During the conference, key executives from Knight Therapeutics will discuss the company’s latest research developments, collaboration efforts, and market strategies. The presentations will likely include insights into the therapeutic areas Knight is focusing on and how these align with current market trends and patient needs. This engagement also signifies Knight's commitment to transparency and investor relations, further solidifying its reputation in the healthcare investment space.

Overall, Knight's participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference exemplifies its proactive approach in enhancing stakeholder engagement. By actively participating in such events, Knight not only boosts its visibility in the competitive healthcare market but also reinforces its dedication to advancing healthcare innovation and delivering value to its shareholders.